GROWING PROBLEM

Did you know that 1-in-5

couples need medical

support to conceive?

%40 of medical issues to conceive are due to men, %40 due to women and the rest is due to both or remains unexplained.

�

Sperm Count declined 59%

while sperm concentration dropped 52%

�

MALE

FERTILITY

CRISIS

Infertility rate for men is over %45,

and %75 of male infertility is due to sperm disorders.

​

GROWING PROBLEM

AWKWARD

CLINICAL

EXPERIENCE

​

Among the couples presenting for fertility evaluation 27% of men do not have sperm testing

PAIN POINT

Home care is

essential now

Covid19 has brought us a new lifestyle that increases the value of at-home care solutions.

COVID19

Home tests are not RELIABLE,

what about at-home sample collection?

It saves from the awkward clinical experience for sperm testing.

It provides access to lab results in the comfort of home and privacy.

It brings more personalized experience for everybody.

It generates reliable results based on analysis by the experts.

MEET

PRIVATE

SECURE

EXCLUSIVE

We will conduct the whole process via a unique code where all of your information remains anonymous.

Gemini Kit is developed to protect your sample for up to 48 hours. Once you’re ready, we will collect your kit from your address and transport it to our partner laboratory.

�

You will receive a comprehensive sperm health report within 24 hours. We also offer sperm freezing service for those who like to secure their fatherhood plans for the future.

​

GEMINI BLOOD COLLECTION KIT

GEMINI SPERM COLLECTION KIT

• Sperm Test (Spemiogram)
• Sperm DNA Test
• Male-hormones Test
• Female-hormones Test
• Liver Function Test
• Baseline Checkup

WE

HAVE

TEST

FOR

EVERYBODY

*We currently have 6 available tests at GeminiLab, and planning to increase to 15 until the end of 2022.

Urology, Male Reproductive Health

Gynecological Diseases, Assisted Reproductive Treatment

Sexology, Psychosexual Therapy

THE SAVIOUR

ONLINE

DOCTOR

COUNSELLING

Indirect Competitors

�

A niche market; Male Fertility Health!

�

COMPETITION

Active across US

​

Own Tech Infrastructure: NO

GDPR Compliant: NO

CE Regulated: NO

Hormone Testing: NO

General Checkup: NO

Active across EUROPE

​

Own Tech Infrastructure: YES

GDPR Compliant: YES

CE Regulated: YES

Hormone Testing: YES

General Checkup: YES

�

​

​

Mobile Applications

Unapproved reports

�Clinics/Laboratories

Poor Customer Experience

�

​

*It is estimated that infertility affects 8–12% of couples globally who usually need IVF treatment.

*Number of married couples in Europe is 130M, 74M in Middle East and 62M in USA.

*Number of 20 - 50 year-old-males in Europe is 300M, 220M in Middle East and 185M in USA.

Global market for freezing is ~5B USD!

​

The numbers spent for sperm testing by the end users in 2019

THE OPPORTUNITY

TURKEY

$80M

MIDDLE EAST

$2.4B

EUROPE

$3B

USA

$1.5B

Market Size; Ireland, UK and Spain

SOM: 8M

TAM: The number of people aged between 22-49

SAM: The number of couples aged between 22-49

SOM: The number of married couples aged between 22-49

​

Since the pricing will be different for each country and service, total market size can be calculated by (Price) X (TAM)

TAM: 22M

SAM: 10.5M

United Kingdom

SOM: 3.6M

TAM: 18M

SAM: 4.2M

Spain

SOM: 650K

SAM: 705K

Ireland

TAM: 1.8M

EUROPE

BUSINESS MODEL

�

D2C

• Couples
• White-collar people
• Subscription

(personalised lifestyle

recommendations)

�

B2B

• Insurance Companies 
• IVF Centers, clinics

��

Sales Channels

​

• Doctors
• Insurance companies
• IVF centres/clinics
• Drug stores, supermarkets

100 paying customers

in 5 months

​

Cost of kit is $15 with %70 gross profit margin

​

25 partner doctors

in 2 months

​

​

​

​

We are in talk with FutureLife to facilitate their clinics in different markets up for to 11 countries.

We partner up with Labmagister, the biggest laboratory in Hungary as well as in Eastern Europe region. Labmagister is also our regional partner for nearby countries such as Czech, Romania, Slovenia etc.

GROWTH

We are in talk with potential partners from different countries such as Germany, Ireland.

BETA LAUNCH

EXPANSION

UK, SPAIN

HUNGARY

TURKEY

OTHERS

2019 H2

​

Business Modeling

​

Market Validation

​

MVP Concept

​

Clinical Studies

​

2020

​

Raised Pre-seed

Investment ($150K)

​

Kit Development

​

Tech Development

​

Partner Lab

Agreement

​

​

2021

​

Product Launch

​

CE Certification

​

Registration at TR Ministry of Health

​

Operational Setup

in TR

​

​

2022

​

Growth, EU Region

​

Freezing Service

​

Male Hormone Testing

​

Female Hormone Testing

​

B2B Aspect

​

​

​

​

​

​

2023

​

Global Insurance Agreements

​

Global Fertility

Alliances

​

Multi-regional Certifications

​

Subscription Model (personalised lifestyle recommendations)

​

​

​

​

MILESTONES

BEHIND GEMINILAB

BEHIND GEMINILAB

We are looking for €1M to expand GeminiLab into different markets 🚀

FUNDRAISING

SEIZE

THE

OPPORTUNITY

�

• According to World Health Organization, 15 couples out of 100 are not be able to conceive within the first year of unprotected sex. While PEW Research Center from USA claims that about 1 in 7 couples are infertile and 20-35% of couples fail to conceive within 6 months, and approximately 15% of couples fail to conceive within 12 months. WHO defines the infertility as “the inability to conceive after 12 months of unprotected intercourse”, or just 6 months if the women is over 35.
• Among the couples going through fertility treatment, the infertility rate for men was 20% thirty years ago and now it’s %45. And 75% of male infertility is due to sperm disorders.
• For western men, sperm count has declined %59 while sperm concentration has 52% drop in the last forty years. On average, sperm count is dropping 1% every year, with no evidence of levelling off.
• A recent study of 2,500 Swiss men between the ages of 18 and 22 found that almost two thirds (62%) had one or more factors below the normal ranges.
• According to a study, among the couples presenting for fertility evaluation %27 of men do not have sperm testing due to various reasons. Beside of social norms, they refuse going through clinical experience for fertility testing.
• A 2008 study comparing SA results from men who collected at home versus in the laboratory found that men collecting at home had higher sperm concentration, total sperm count, and progressive motility (5). A 2014 study had similar findings, with home-collection samples having larger volumes (4.0 vs. 4.9 mL), sperm concentration (41 vs. 64 million/mL), and progressive sperm motility (40 vs. 52%)
• The studies show that 40% of couple who are going through IVF (in-vitro-fertilization) treatment relate the issue to men, %40 to women, and the rest relates the issue to both or unexplained cases.
• The European IVF Market was valued at $3,054 million in 2015 and is estimated to reach $4,447 million by 2022, growing at a CAGR of 5.4% . The four European countries with the largest treatment numbers in 2015 were Spain (119 875 treatments), Russia (110723), Germany (96512) and France (93918). The average cost of an IVF cycle in Europe is €4000-5000, and the average number of cycles for a successful pregnancy is three.
• The number of married couples in Europe is 130M, 74M in MENA, 62M in USA and 1.5B in Asia. And The number of 20-49 year-old-men in Europe is 350M, 300M in MENA, 185M in USA and 2.2B in Asia.
• The CDC (The Centers for Disease Control and Prevention is the national public health agency of the United States.) noted in July 2019 that the US fertility rate fell to an ‘all-time low’ of 1.72 children per women. Meanwhile, England saw its lowest birth rate since records began, down almost 50% since its peak in 1947. Western Europe has the lowest total fertility rate in the world, at just 1.6 children/woman.

APPENDIX - STATISTICS

THE FACTS IN FERTILITY HEALTH